Literature DB >> 3000604

Chemoattractant-elicited increases in myosin phosphorylation in Dictyostelium.

C H Berlot, J A Spudich, P N Devreotes.   

Abstract

Cyclic AMP stimulation of chemotactically competent Dictyostelium amebas labeled with [32P]orthophosphate transiently increases phosphorylation in the heavy chain and the 18,000 dalton light chain of myosin. Immediately before the increase, heavy chain phosphorylation transiently decreases. These phosphorylation changes also occur when cAMP-induced activation of adenylate cyclase is blocked by pretreatment of amebas with caffeine. The time course of these phosphorylation responses correlates with the shape changes induced in amebas exposed to a temporal increase in cAMP concentration. The dose dependence of the phosphorylation responses is the same as that previously determined for chemotaxis. The phosphorylation responses exhibit adaptation properties in common with those of the shape change response and chemotaxis. Increases in the rate of myosin heavy chain and light chain phosphorylation can be observed in vitro by stimulating unlabeled amebas with cAMP and then lysing the cells into a gamma-[32P]ATP-containing reaction mixture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000604     DOI: 10.1016/0092-8674(85)90036-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  54 in total

1.  Expression of chicken gizzard RLC complements the cytokinesis and developmental defects of Dictyostelium RLC null cells.

Authors:  P Chen; B M Chaudoir; K M Trybus; R L Chisholm
Journal:  J Muscle Res Cell Motil       Date:  1999-02       Impact factor: 2.698

Review 2.  Signaling pathways regulating Dictyostelium myosin II.

Authors:  Marc A De la Roche; Janet L Smith; Venkaiah Betapudi; Thomas T Egelhoff; Graham P Côté
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

3.  Membrane-bound Dictyostelium myosin heavy chain kinase: a developmentally regulated substrate-specific member of the protein kinase C family.

Authors:  S Ravid; J A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

4.  Genetically engineered truncated myosin in Dictyostelium: the carboxyl-terminal regulatory domain is not required for the developmental cycle.

Authors:  T J O'Halloran; J A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Propagating waves separate two states of actin organization in living cells.

Authors:  Britta Schroth-Diez; Silke Gerwig; Mary Ecke; Reiner Hegerl; Stefan Diez; Günther Gerisch
Journal:  HFSP J       Date:  2009-11-30

6.  14-3-3 inhibits the Dictyostelium myosin II heavy-chain-specific protein kinase C activity by a direct interaction: identification of the 14-3-3 binding domain.

Authors:  M Matto-Yelin; A Aitken; S Ravid
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

7.  A cell number-counting factor regulates the cytoskeleton and cell motility in Dictyostelium.

Authors:  Lei Tang; Tong Gao; Catherine McCollum; Wonhee Jang; Michael G Vicker; Robin R Ammann; Richard H Gomer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

8.  Myosin light chain kinase (MLCK) gene disruption in Dictyostelium: a role for MLCK-A in cytokinesis and evidence for multiple MLCKs.

Authors:  J L Smith; L A Silveira; J A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

9.  MLCK-A, an unconventional myosin light chain kinase from Dictyostelium, is activated by a cGMP-dependent pathway.

Authors:  L A Silveira; J L Smith; J L Tan; J A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 10.  Moving towards a paradigm: common mechanisms of chemotactic signaling in Dictyostelium and mammalian leukocytes.

Authors:  Yulia Artemenko; Thomas J Lampert; Peter N Devreotes
Journal:  Cell Mol Life Sci       Date:  2014-05-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.